Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.
作者信息
Ramaswami Ramya, Lurain Kathryn, Peer Cody J, Serquiña Anna, Wang Victoria, Widell Anaida, Goncalves Priscila, Steinberg Seth M, Marshall Vickie, George Jomy, Figg William D, Whitby Denise, Ziegelbauer Joseph, Uldrick Thomas S, Yarchoan Robert
机构信息
HIV & AIDS Malignancy Branch.
Clinical Pharmacology Program, and.
出版信息
Blood. 2020 Jun 18;135(25):2316-2319. doi: 10.1182/blood.2019004602.
Abstract
摘要
相似文献
1
Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.托珠单抗治疗有症状的卡波西肉瘤疱疹病毒相关多中心性Castleman病患者。
Blood. 2020 Jun 18;135(25):2316-2319. doi: 10.1182/blood.2019004602.
2
High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.高剂量齐多夫定联合缬更昔洛韦治疗卡波西肉瘤疱疹病毒相关多中心 Castleman 病：病毒激活细胞毒性治疗的初步研究。
Blood. 2011 Jun 30;117(26):6977-86. doi: 10.1182/blood-2010-11-317610. Epub 2011 Apr 12.
3
Coexistence of disseminated Kaposi sarcoma and multicentric Castleman disease in an HIV-infected patient under viral suppression.HIV 感染者病毒抑制状态下弥漫性卡波西肉瘤和多中心 Castleman 病共存。
Int J STD AIDS. 2021 Mar;32(3):286-289. doi: 10.1177/0956462420968385. Epub 2021 Feb 8.
4
Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease.利妥昔单抗用于经利妥昔单抗预处理的HIV相关多中心Castleman病的再次治疗。
Blood. 2007 Dec 1;110(12):4132-3. doi: 10.1182/blood-2007-08-106187.
5
Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.利妥昔单抗联合脂质体阿霉素治疗合并卡波西肉瘤相关多中心Castleman病的HIV感染患者。
Blood. 2014 Dec 4;124(24):3544-52. doi: 10.1182/blood-2014-07-586800. Epub 2014 Oct 20.
6
HIV-associated multicentric Castleman disease: a report of 19 cases at an oncology institution.人类免疫缺陷病毒相关多中心性Castleman病：一家肿瘤机构19例报告
Int J STD AIDS. 2020 Mar;31(4):318-325. doi: 10.1177/0956462420905277. Epub 2020 Feb 23.
7
Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.卡波西肉瘤疱疹病毒相关多中心 Castleman 病的最新进展。
Curr Opin Oncol. 2012 Sep;24(5):495-505. doi: 10.1097/CCO.0b013e328355e0f3.
8
Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders.在卡波西肉瘤相关疱疹病毒相关疾病中检测病毒白细胞介素-6
Blood. 2001 Apr 1;97(7):2173-6. doi: 10.1182/blood.v97.7.2173.
9
HHV8-associated lymphoproliferative disorder in the peripheral blood.外周血中与HHV8相关的淋巴增殖性疾病。
Blood. 2018 Jun 21;131(25):2868. doi: 10.1182/blood-2018-04-837823.
10
[Favorable outcome of Castleman's disease treated with oral valganciclovir].口服缬更昔洛韦治疗Castleman病的良好疗效
Med Clin (Barc). 2005 Sep 24;125(10):399. doi: 10.1157/13079178.
引用本文的文献
1
Lymphoproliferations in People Living with HIV: Oncogenic Pathways, Diagnostic Challenges, and New Therapeutic Opportunities.HIV感染者的淋巴细胞增殖：致癌途径、诊断挑战及新的治疗机遇
Cancers (Basel). 2025 Jun 22;17(13):2088. doi: 10.3390/cancers17132088.
2
Kaposi sarcoma herpesvirus (KSHV) inflammatory cytokine syndrome (KICS): a case study.卡波西肉瘤疱疹病毒（KSHV）炎性细胞因子综合征（KICS）：一项病例研究。
BMC Infect Dis. 2025 Apr 21;25(1):569. doi: 10.1186/s12879-025-10852-3.
3
The Role of vIL-6 in KSHV-Mediated Immune Evasion and Tumorigenesis.病毒白细胞介素-6在卡波西肉瘤相关疱疹病毒介导的免疫逃逸和肿瘤发生中的作用
Viruses. 2024 Dec 10;16(12):1900. doi: 10.3390/v16121900.
4
Immune Characteristics and Immunotherapy of HIV-Associated Lymphoma.人类免疫缺陷病毒相关淋巴瘤的免疫特征与免疫治疗
Curr Issues Mol Biol. 2024 Sep 10;46(9):9984-9997. doi: 10.3390/cimb46090596.
5
The Cytokine Storm of Multicentric Castleman Disease.多中心Castleman 病的细胞因子风暴。
Adv Exp Med Biol. 2024;1448:459-467. doi: 10.1007/978-3-031-59815-9_31.
6
The clinical picture of Castleman disease: a systematic review and meta-analysis.卡斯特曼病的临床特征：一项系统评价和荟萃分析。
Blood Adv. 2024 Sep 24;8(18):4924-4935. doi: 10.1182/bloodadvances.2024013548.
7
Inflammasome activation in patients with Kaposi sarcoma herpesvirus-associated diseases.卡波西肉瘤疱疹病毒相关疾病患者的炎症小体激活。
Blood. 2024 Oct 3;144(14):1496-1507. doi: 10.1182/blood.2024024144.
8
HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus.人类免疫缺陷病毒相关癌症和卡波西肉瘤疱疹病毒与 Epstein-Barr 病毒引起的淋巴组织增生性疾病。
Clin Microbiol Rev. 2024 Sep 12;37(3):e0002223. doi: 10.1128/cmr.00022-23. Epub 2024 Jun 20.
9
Pacritinib inhibits proliferation of primary effusion lymphoma cells and production of viral interleukin-6 induced cytokines.帕西替尼抑制原发性渗出性淋巴瘤细胞的增殖以及病毒白细胞介素-6诱导的细胞因子的产生。
Sci Rep. 2024 Feb 19;14(1):4125. doi: 10.1038/s41598-024-54453-7.
10
Pediatric HIV+ Kaposi sarcoma exhibits clinical, virological, and molecular features different from the adult disease.儿科 HIV+ 卡波西肉瘤表现出与成人疾病不同的临床、病毒学和分子特征。
JCI Insight. 2023 Nov 22;8(22):e167854. doi: 10.1172/jci.insight.167854.
本文引用的文献
1
Emergence of Kaposi's Sarcoma Herpesvirus-Associated Complications Following Corticosteroid Use in TB-IRIS.结核病免疫重建炎症综合征中使用皮质类固醇后卡波西肉瘤疱疹病毒相关并发症的出现
Open Forum Infect Dis. 2018 Oct 12;5(10):ofy217. doi: 10.1093/ofid/ofy217. eCollection 2018 Oct.
2
HIV-Associated Cancers and Related Diseases.艾滋病相关癌症及相关疾病
N Engl J Med. 2018 Mar 15;378(11):1029-1041. doi: 10.1056/NEJMra1615896.
3
Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease.卡波西肉瘤疱疹病毒相关多中心性Castleman病的治疗
Hematol Oncol Clin North Am. 2018 Feb;32(1):75-88. doi: 10.1016/j.hoc.2017.09.007.
4
Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients.利妥昔单抗治疗 HIV 阳性患者后，HHV8 阳性多中心 Castleman 病复发。
Blood. 2017 Apr 13;129(15):2143-2147. doi: 10.1182/blood-2016-10-747477. Epub 2017 Jan 31.
5
Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.利妥昔单抗联合脂质体阿霉素治疗合并卡波西肉瘤相关多中心Castleman病的HIV感染患者。
Blood. 2014 Dec 4;124(24):3544-52. doi: 10.1182/blood-2014-07-586800. Epub 2014 Oct 20.
6
Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.人类和病毒白细胞介素-6 和其他细胞因子在卡波西肉瘤疱疹病毒相关的多中心 Castleman 病中的作用。
Blood. 2013 Dec 19;122(26):4189-98. doi: 10.1182/blood-2013-08-519959. Epub 2013 Oct 30.
7
HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice.HHV-8 编码的病毒 IL-6 与小鼠 IL-6 合作在小鼠中引发多中心 Castleman 病。
Blood. 2012 May 31;119(22):5173-81. doi: 10.1182/blood-2011-09-377705. Epub 2012 Apr 9.
8
High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.高剂量齐多夫定联合缬更昔洛韦治疗卡波西肉瘤疱疹病毒相关多中心 Castleman 病：病毒激活细胞毒性治疗的初步研究。
Blood. 2011 Jun 30;117(26):6977-86. doi: 10.1182/blood-2010-11-317610. Epub 2011 Apr 12.
9
How I treat HIV-associated multicentric Castleman disease.我如何治疗 HIV 相关多中心 Castleman 病。
Blood. 2010 Nov 25;116(22):4415-21. doi: 10.1182/blood-2010-07-290213. Epub 2010 Aug 5.
10
Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling.人源化抗IL-6R抗体托珠单抗对IL-6信号天然抑制剂可溶性gp130活性的影响。
Rheumatol Int. 2009 Feb;29(4):397-401. doi: 10.1007/s00296-008-0703-8. Epub 2008 Sep 20.
Zotero 插件